BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11166003)

  • 1. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
    Lanas AI
    Am J Med; 2001 Jan; 110(1A):70S-73S. PubMed ID: 11166003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding.
    Lanas A; Ferrández A
    Expert Opin Drug Saf; 2002 Sep; 1(3):245-52. PubMed ID: 12904140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J; Saito Y; Honda A; Matsuzaki Y
    World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
    Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M
    Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
    Pilotto A; Franceschi M; Longoa MG; Scarcelli C; Orsitto G; Perri FC; D'Ambrosio LP; Leandro G
    Dig Liver Dis; 2004 Oct; 36(10):666-70. PubMed ID: 15506665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
    Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
    N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M; Bianchi Porro G
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
    Maiden LP; Harris AW
    N Engl J Med; 2002 Nov; 347(20):1623-4; author reply 1623-4. PubMed ID: 12432054
    [No Abstract]   [Full Text] [Related]  

  • 13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
    Graham DY
    Helicobacter; 2002 Feb; 7(1):1-8. PubMed ID: 11886469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
    Naesdal J; Wilson I
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole.
    Lanas A; Rodrigo L; Márquez JL; Bajador E; Pérez-Roldan F; Cabrol J; Quintero E; Montoro M; Gomollón F; Santolaria S; Lorente S; Cucala M; Nuevo J;
    Scand J Gastroenterol; 2003 Jul; 38(7):693-700. PubMed ID: 12889553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aspirin: protection from the panacea.
    Guda N; Vakil N
    Am J Gastroenterol; 2002 Dec; 97(12):3202-3. PubMed ID: 12492214
    [No Abstract]   [Full Text] [Related]  

  • 18. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
    Leung Ki EL; Chan FK
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.